HECTD2 and hepatocellular carcinoma: To investigate the mechanism underlying HECTD2‐mediated lenvatinib resistance in HCC, we first performed protein sequencing of lenvatinib‐sensitive Huh7 cells with or without HECTD2 overexpression, establishing the landscape of differentially expressed proteins upon HECTD2 overexpression (Figure3A).